March 1, 2019 06:39 AM EST

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

Natalie Grover

Reporter

Less than two years after Horizon Pharma $HZNP procured phase III-ready thyroid eye disease (TED) drug teprotumumab for $145 million upfront by acquiring a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

Natalie Grover

Reporter

Sign up to read this article for free.

Novartis turns to BioAge for new targets based on longevity and exercise

Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs

Post-Hoc: Biosecure is dead. Long live Biosecure?

US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total

Novartis, AbbVie and PhRMA secure 340B court win in West Virginia

Merck’s long-awaited obesity move is an oral GLP-1 from China

Af­ter thy­roid eye drug scores in PhI­II test, Hori­zon Phar­ma read­ies mar­ket­ing ap­pli­ca­tion

Natalie Grover

Reporter

Sign up to read this article for free.

more like this

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

Post-Hoc: Biose­cure is dead. Long live Biose­cure?

US spent $450B on drugs last year, CMS says, with new obe­si­ty and di­a­betes drugs adding to to­tal

No­var­tis, Ab­b­Vie and PhRMA se­cure 340B court win in West Vir­ginia

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

Novartis turns to BioAge for new targets based on longevity and exercise

Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs

Post-Hoc: Biosecure is dead. Long live Biosecure?

US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total

Novartis, AbbVie and PhRMA secure 340B court win in West Virginia

Merck’s long-awaited obesity move is an oral GLP-1 from China